Apis Capital Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History

Apis Capital Advisors’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$358K	Buy	113,000 +36,000	+47%	+$109K	0.5%	27
2015 Q2	$233K	Sell	77,000 -3,000	-4%	-$8.43K	0.26%	32
2015 Q1	$133K	Buy	80,000 +5,000	+7%	+$16.4K	0.18%	36
2014 Q4	$333K	Buy	+75,000	New	+$358K	0.37%	29

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LSVM

Lone Star Value Management Old Greenwich, Connecticut $52.7M AUM 30.18% 1-Year Est. Return

KIA

Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

MAG

Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return

Apis Capital Advisors's ENZ Position: Q3 2015 in Review

Apis Capital Advisors increased its Enzo Biochem, Inc. (ENZ) stake by 47% in Q3 2015, buying an estimated $109K and bringing the position to 113,000 shares worth $358K. The position accounts for 0.5% of the portfolio, ranked #27.

Apis Capital Advisors first reported a position in ENZ in Q4 2014 and has held it in 4 quarters since. 82 funds tracked by Wall St. Rank hold ENZ as of Q3 2015.

Apis Capital Advisors held 113,000 shares of Enzo Biochem, Inc. worth $358K as of Q3 2015.
Apis Capital Advisors bought 36,000 Enzo Biochem, Inc. shares in Q3 2015, an estimated $109K.
Enzo Biochem, Inc. made up 0.5% of Apis Capital Advisors's portfolio in Q3 2015, its #27 holding.
Apis Capital Advisors first reported a position in Enzo Biochem, Inc. in Q4 2014 and has held it in 4 quarters since.
82 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2015.

Based on Apis Capital Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.